Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda

E Nuwamanya, SC Nassiwa, A Kuznik, C Waitt… - Value in Health …, 2024 - Elsevier
Objectives Dolutegravir (DTG) has proved to be more efficacious, tolerable, and safer than
efavirenz (EFV) among mothers living with HIV and their infants in Uganda. This study …

[PDF][PDF] Editor's choice: COVID-19 and other infections in Africa

JK Tumwine - African Health Sciences, 2023 - ajol.info
Welcome to this March 2023 issue of African Health Sciences, in which infectious diseases
and sexual reproductive and child health issues take center stage. Rightly so, because …